WASHINGTON, DC, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Nexford University today announced the launch of ...
Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...
Switzerland’s economic resilience is showcasing the prowess of one of Europe’s most business-friendly domains, where ...
Switzerland’s economic resilience is showcasing the prowess of one of Europe’s most business-friendly domains, where ...
Its March 20 $29 put had the highest unusual options activity on the day with a Vol/OI (volume-to-open-interest) ratio of 210 ...
In this week’s edition of The Prototype, we look at building a virtual fusion power plant, a major quantum breakthrough, AI ...
Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...
Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to ...
In markets, short-term underperformance can often set the stage for a compelling long-term opportunity. Although healthcare ...
Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, ...
The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap ...
Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback